tofacitinib,baricitinib
pfizer,eli lilly,incyte
['tofacitinib', ' aa ', 'rheumatoid,arthritis', 'tofa', 'baricitinib']
jaki use did not increase cv risk compared to tnf, no difference between bari and tofa, non significant increased irr in patients &gt;65 years, merel opdam, abst#op0221 #eular2023 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Health,NASS Trustee, Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach